Kovack Advisors, Inc. Chembio Diagnostics, Inc. Transaction History

Kovack Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2017 Aug 02, 2018	SELL	$5.85 - $6.2 $95,056 - $100,743	-16,249 Closed	0 $0
Q2 2017 Aug 30, 2018	SELL	N/A	-2,000 Reduced 10.96%	16,249 $98,000
Q1 2017 Sep 05, 2018	SELL	N/A	-15,260 Reduced 45.54%	18,249 $97,000
Q4 2016 Sep 10, 2018	BUY	N/A	33,509	33,509 $228,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.